BAS Stock Analysis: BASF SE | XETRA
Chemicals | XETRA, Germany | Market Cap: 43.305m EUR | 12M Return: 12.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 88.4M
Qual. Beats: 1
Rev. Trend: -92.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BASF SE is a Germany-headquartered global chemical company founded in 1865, operating through six business segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The segments span a vertically integrated portfolio from petrochemicals and intermediates to advanced materials, industrial additives, automotive and battery materials, consumer nutrition and care ingredients, and crop protection products. The company is categorized in the GICS Commodity Chemicals sub-industry within the Materials sector, and also engages in engineering, leasing, and renewable energy and commodity trading activities.
- European gas costs pressure integrated Verbund site margins
- Agricultural Solutions faces pricing headwinds from weak global crop prices
- Automotive OEM coatings demand softens with slower EV adoption
| Net Income: 5.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.66 > 1.0 |
| NWC/Revenue: 29.15% < 20% (prev 24.0%; Δ 5.15% < -1%) |
| CFO/TA 0.07 > 3% & CFO 5.79b > Net Income 5.76b |
| Net Debt (22.0b) to EBITDA (8.10b): 2.72 < 3 |
| Current Ratio: 1.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (878.4m) vs 12m ago -1.59% < -2% |
| Gross Margin: 26.25% > 18% (prev 25.57%; Δ 0.68% > 0.5%) |
| Asset Turnover: 75.47% > 50% (prev 77.19%; Δ -1.72% > 0%) |
| Interest Coverage Ratio: 5.37 > 6 (EBIT TTM 4.41b / Interest Expense TTM 820.0m) |
| A: 0.22 (Total Current Assets 37.6b - Total Current Liabilities 19.7b) / Total Assets 81.8b |
| B: 0.37 (Retained Earnings 30.4b / Total Assets 81.8b) |
| C: 0.05 (EBIT TTM 4.41b / Avg Total Assets 81.6b) |
| D: 0.74 (Book Value of Equity 34.3b / Total Liabilities 46.3b) |
| Altman-Z'' = 3.79 = AA |
| DSRI: 0.78 (Receivables 12.1b/15.9b, Revenue 61.6b/62.9b) |
| GMI: 0.97 (GM 25.57% / 26.25%) |
| AQI: 0.85 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 0.98 (Revenue 61.6b / 62.9b) |
| TATA: -0.00 (NI 5.76b - CFO 5.79b) / TA 81.8b) |
| Beneish M = -3.33 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at EUR 48.21 with a total of 1,953,944 shares traded. Over the past week, the price has changed by +0.29%, over one month by +2.73%, over three months by -7.23% and over the past year by +12.22%.
Current recommended Stop Loss: 45.60 (which is 5.4% or 2.4 ATR below the current price).
BASF SE has no consensus analysts rating.
P/E Trailing = 28.8059
P/E Forward = 20.284
P/S = 0.7211
P/B = 1.24
P/EG = 0.7047
Revenue TTM = 61.6b EUR
EBIT TTM = 4.41b EUR
EBITDA TTM = 8.10b EUR
Long Term Debt = 19.9b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.76b EUR (from shortTermDebt, last quarter)
Debt = 25.2b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.55b
Net Debt = 22.0b EUR (calculated: Debt 25.2b - CCE 3.18b)
Enterprise Value = 65.3b EUR (43.3b + Debt 25.2b - CCE 3.18b)
Interest Coverage Ratio = 5.37 (Ebit TTM 4.41b / Interest Expense TTM 820.0m)
EV/FCF = 37.00x (Enterprise Value 65.3b / FCF TTM 1.77b)
FCF Yield = 2.70% (FCF TTM 1.77b / Enterprise Value 65.3b)
FCF Margin = 2.87% (FCF TTM 1.77b / Revenue TTM 61.6b)
Net Margin = 9.35% (Net Income TTM 5.76b / Revenue TTM 61.6b)
Gross Margin = 26.25% ((Revenue TTM 61.6b - Cost of Revenue TTM 45.4b) / Revenue TTM)
Gross Margin QoQ = none% (prev 25.92%)
Tobins Q-Ratio = 0.80 (Enterprise Value 65.3b / Total Assets 81.8b)
Interest Expense / Debt = 3.25% (Interest Expense 820.0m / Debt 25.2b)
Taxrate = 37.07% (907.0m / 2.45b)
NOPAT = 2.77b (EBIT 4.41b * (1 - 37.07%))
Current Ratio = 1.91 (Total Current Assets 37.6b / Total Current Liabilities 19.7b)
Debt / Equity = 0.74 (Debt 25.2b / totalStockholderEquity, last quarter 34.3b)
Debt / EBITDA = 2.72 (Net Debt 22.0b / EBITDA 8.10b)
Debt / FCF = 12.48 (Net Debt 22.0b / FCF TTM 1.77b)
Total Stockholder Equity = 33.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.06% (Net Income 5.76b / Total Assets 81.8b)
RoE = 17.37% (Net Income TTM 5.76b / Total Stockholder Equity 33.1b)
RoCE = 8.30% (EBIT 4.41b / Capital Employed (Equity 33.1b + L.T.Debt 19.9b))
RoIC = 4.42% (NOPAT 2.77b / Invested Capital 62.8b)
WACC = 5.57% (E(43.3b)/V(68.5b) * Re(7.63%) + D(25.2b)/V(68.5b) * Rd(3.25%) * (1-Tc(0.37)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.36 | Cagr: 0.07%
[DCF] Terminal Value 77.97% ; FCFF base≈1.22b ; Y1≈1.40b ; Y5≈2.06b
[DCF] Fair Price = 10.16 (EV 31.0b - Net Debt 22.0b = Equity 8.98b / Shares 884.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 3.19 | # QB: 1
Revenue Correlation: -92.22 | Revenue CAGR: -5.23% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.88 | Chg30d=+7.76% | Revisions=-25% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.36 | Chg30d=-9.41% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=2.77 | Chg30d=+1.80% | Revisions=-10% | GrowthEPS=+23.7% | GrowthRev=+6.2%
EPS next Year (2027-12-31): EPS=2.93 | Chg30d=-0.86% | Revisions=-10% | GrowthEPS=+5.6% | GrowthRev=+1.1%
[Analyst] Revisions Ratio: -21% (up=6, down=10)